Goldbach, Pierre,Mahler, Hanns-Christian,Mueller, Robert
申请号：
AU2013229613
公开号：
AU2013229613B2
申请日:
2013.03.05
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The present invention relates to a pharmaceutical formulation comprising about 50 mg/ml – 200 mg/ml of an Abeta antibody, about 0.01 % – 0.1% poloxamer, about 5 mM – 50 mM of a buffer, about 100 m M – 300 m M of a stabilizer at a pH of about 4.5 – 7.0.
